Network meta-analysis compares DOACs and VKAs for intracranial hemorrhage risk
Dabigatran may be safest for brain bleeding risk
This network meta-analysis of 127,267 patients with venous thromboembolism or atrial fibrillation found that all DOACs had lower risk of int…
All blood thinners beat warfarin for brain bleed risk, but dabigatran may be the safest choice.
DOACs versus VKAs for left ventricular thrombus management in adults
Newer Blood Thinners May Be Safer for Heart Clot Patients
A meta-analysis suggests DOACs may be a reasonable alternative to VKAs for left ventricular thrombus, with similar efficacy and potentially …
If you have a blood clot in your heart, newer blood thinners may be just as effective as warfarin with a lower risk of dangerous bleeding.
Network meta-analysis compares prophylactic anticoagulants for central venous catheter-related thrombosis in cancer patients
Cancer Patients May Avoid Clots With Safer Blood Thinner
This network meta-analysis synthesizes data from 19 clinical studies regarding prophylactic anticoagulation in cancer patients with central …
A new analysis shows one specific blood thinner may protect cancer patients from dangerous clots with fewer side effects.
Apixaban alters hemostatic biomarkers in children with heart disease compared to standard care
New Blood Test Shows Apixaban Works Safely in Kids
This exploratory biomarker substudy of an RCT in children over one year with heart disease assessed apixaban versus standard care (vitamin K…
A new blood test confirms apixaban works safely for children with heart disease, offering a simpler alternative to painful injections and fr…